Smartlab Europe

Xyntek forms strategic alliance with Antares Vision

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

It’s Time for the 3rd Generation of Patient Recruitment

Key Takeaways 80% of clinical trials experience enrolment delays and massive...
- Advertisement -

Xyntek has entered into a strategic alliance with a provider of e-pedigree and serialization technology and solutions, Antares Vision.

Xyntek is involved in providing real-time automated IT systems and microprocessor based industrial automation solutions to the life sciences industries.

Xyntek president and CEO Mac Hashemian said the strategic partnership with Antares Vision provides the company with the core e-pedigree and serialization technology needed to provide its customers turn-key serialization and e-pedigree solutions.

” Antares Vision has applied its technology to the largest number of installed and operational serialization and aggregation production lines and packages with track and trace applied on a worldwide basis,” Hashemian added.

Antares Vision CEO Emidio Zorzella said the company’s partnership with Xyntek is a strategic and fundamental step to improve its competitiveness in relation to major international players.

“With our joint and mutually exclusive U.S. partnership, together we will become the world’s 1 provider of turn-key e-pedigree, track and trace, serialization, brand security and protection, anti-counterfeiting, and anti-drug diversion solutions,” Zorzella added.

Latest stories

Related stories

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

It’s Time for the 3rd Generation of Patient Recruitment

Key Takeaways 80% of clinical trials experience enrolment delays and massive...

Driving Documentation Integrity Through Structured Drug Data

Establishing a robust framework for regulatory success requires moving beyond fragmented information silos toward a unified, digital-first approach. Comprehensive oversight of the pharmaceutical lifecycle depends on the ability to transform raw information into actionable insights, ensuring that every data point contributes to a larger narrative of safety and efficacy. By prioritizing specialized platforms that aggregate and organize complex information, organizations can achieve a level of transparency that satisfies the most stringent global standards while fostering a culture of continuous improvement.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »